Welcome to VanEck
VanEck is a global investment manager with offices around the world. To help you find content that is suitable for your investment needs, please select your country and investor type.
WuXi Biologics, a leading Chinese healthcare name, is an example of how pockets of alpha can be found where companies are providing solutions to problems caused by the novel coronavirus outbreak.
If you look past short-term headlines and focus on long-term, structural growth opportunities, healthcare in China is poised for innovation and disruption as evidenced by Ping An Good Doctor and BeiGene.
We believe the outlook for emerging markets equities is bright and expect growth to be the main driver of returns in 2020.
We take a look at the Financials sector in emerging markets, its composition and our approach to allocating to this sector.
Amid downward revisions in global growth and the direction of monetary policy, we remain focused on companies at good valuations that address nascent areas of demand in emerging markets.
© 2020 VanEck.